Showing 97 to 108 of 152 results
EU Pharmaceutical Lobby Challenges Wastewater Directive
The pharmaceutical and cosmetic industry challenged an EU directive requiring them to pay for 80% of wastewater micropollutant removal, citing unfair cost distribution and lack of data transparency; the EU estimates annual costs at €1.2 billion.
EU Pharmaceutical Lobby Challenges Wastewater Directive
The pharmaceutical and cosmetic industry challenged an EU directive requiring them to pay for 80% of wastewater micropollutant removal, citing unfair cost distribution and lack of data transparency; the EU estimates annual costs at €1.2 billion.
Progress
36% Bias Score
AstraZeneca Invests $2.5 Billion in Beijing R&D Center
AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global R&D center, partnering with three Chinese biotech companies and the Beijing Cancer Hospital, aiming to leverage China's life sciences ecosystem and expand its global reach.
AstraZeneca Invests $2.5 Billion in Beijing R&D Center
AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global R&D center, partnering with three Chinese biotech companies and the Beijing Cancer Hospital, aiming to leverage China's life sciences ecosystem and expand its global reach.
Progress
52% Bias Score
Trump and Martin Meet Amid Trade Tensions
During a Wednesday Oval Office meeting, President Trump and Irish Taoiseach Micheal Martin discussed trade relations, with Trump criticizing Ireland's pharmaceutical industry and tax policies while acknowledging the importance of their bilateral relationship; this follows recent trade disputes and a...
Trump and Martin Meet Amid Trade Tensions
During a Wednesday Oval Office meeting, President Trump and Irish Taoiseach Micheal Martin discussed trade relations, with Trump criticizing Ireland's pharmaceutical industry and tax policies while acknowledging the importance of their bilateral relationship; this follows recent trade disputes and a...
Progress
60% Bias Score
Trump Threatens Tariffs on Irish Goods Over Tax Policies
During a St. Patrick's Day meeting, President Trump voiced concerns about Ireland's tax policies attracting U.S. pharmaceutical companies, hinting at potential future tariffs despite acknowledging the strong U.S.-Ireland trade relationship and the risk to his Irish-American voter base.
Trump Threatens Tariffs on Irish Goods Over Tax Policies
During a St. Patrick's Day meeting, President Trump voiced concerns about Ireland's tax policies attracting U.S. pharmaceutical companies, hinting at potential future tariffs despite acknowledging the strong U.S.-Ireland trade relationship and the risk to his Irish-American voter base.
Progress
60% Bias Score
Pharmaceutical Layoffs Reflect Industry Pressures and Strategic Challenges
Facing financial pressures from natural business cycles and regulatory changes, major pharmaceutical companies like Moderna, Biogen, and Johnson & Johnson are laying off employees, raising concerns about the future of research and development.
Pharmaceutical Layoffs Reflect Industry Pressures and Strategic Challenges
Facing financial pressures from natural business cycles and regulatory changes, major pharmaceutical companies like Moderna, Biogen, and Johnson & Johnson are laying off employees, raising concerns about the future of research and development.
Progress
36% Bias Score
German Chemical Industry Forecasts Stagnant Production, Slight Revenue Drop in 2025
Germany's chemical and pharmaceutical industry forecasts stagnant production and a 1% revenue drop to €219 billion in 2025, despite stable employment at 480,000, as high energy costs and weak domestic demand affect chemical production, while pharmaceuticals see growth in exports.
German Chemical Industry Forecasts Stagnant Production, Slight Revenue Drop in 2025
Germany's chemical and pharmaceutical industry forecasts stagnant production and a 1% revenue drop to €219 billion in 2025, despite stable employment at 480,000, as high energy costs and weak domestic demand affect chemical production, while pharmaceuticals see growth in exports.
Progress
40% Bias Score
US Drug Overdose Deaths Fall 25%, but Medicaid Cuts Pose Threat
Fatal drug overdoses in the US declined by 25% in the year ending October 2024, with decreased fentanyl deaths leading the way; however, 82,000 overdose deaths still occurred, and proposed Medicaid cuts could reverse this trend.
US Drug Overdose Deaths Fall 25%, but Medicaid Cuts Pose Threat
Fatal drug overdoses in the US declined by 25% in the year ending October 2024, with decreased fentanyl deaths leading the way; however, 82,000 overdose deaths still occurred, and proposed Medicaid cuts could reverse this trend.
Progress
48% Bias Score
Hessian Chemical Industry Faces Revenue Drop Amidst Pharmaceutical Growth, US Trade Tensions
The Hessian chemical industry faced an 11% revenue drop to extasciitilde13.2 billion euros in 2024, while pharmaceutical sales grew by 8% to extasciitilde18 billion euros; however, this is threatened by potential US trade conflicts, impacting exports of approximately 3 billion euros; despite this, 1...
Hessian Chemical Industry Faces Revenue Drop Amidst Pharmaceutical Growth, US Trade Tensions
The Hessian chemical industry faced an 11% revenue drop to extasciitilde13.2 billion euros in 2024, while pharmaceutical sales grew by 8% to extasciitilde18 billion euros; however, this is threatened by potential US trade conflicts, impacting exports of approximately 3 billion euros; despite this, 1...
Progress
48% Bias Score
Trump's Accusations Prompt Prediction of US Pharma Profit Repatriation from Ireland
US President Donald Trump accused Ireland of facilitating tax avoidance by US pharmaceutical companies, prompting experts to predict profit repatriation to the US rather than plant closures; Ireland's corporate tax revenue heavily relies on these companies, creating significant economic vulnerabilit...
Trump's Accusations Prompt Prediction of US Pharma Profit Repatriation from Ireland
US President Donald Trump accused Ireland of facilitating tax avoidance by US pharmaceutical companies, prompting experts to predict profit repatriation to the US rather than plant closures; Ireland's corporate tax revenue heavily relies on these companies, creating significant economic vulnerabilit...
Progress
40% Bias Score
Digitalization Boosts TCM's Global Reach
Chinese pharmaceutical companies are using digital technologies, such as AI and cloud computing, to improve the quality, traceability, and global reach of Traditional Chinese Medicine (TCM) products; this includes using QR codes for detailed product information and high-frequency vibration technolog...
Digitalization Boosts TCM's Global Reach
Chinese pharmaceutical companies are using digital technologies, such as AI and cloud computing, to improve the quality, traceability, and global reach of Traditional Chinese Medicine (TCM) products; this includes using QR codes for detailed product information and high-frequency vibration technolog...
Progress
48% Bias Score
German Chemical Industry Forecasts Stagnation for 2025
Germany's chemical and pharmaceutical industry faces a challenging 2025, with projected stagnation and a 1% turnover decrease to €219 billion, following a 2% drop in 2024; however, pharmaceutical production is expected to increase by 2%, offsetting job losses in the chemical sector, while high energ...
German Chemical Industry Forecasts Stagnation for 2025
Germany's chemical and pharmaceutical industry faces a challenging 2025, with projected stagnation and a 1% turnover decrease to €219 billion, following a 2% drop in 2024; however, pharmaceutical production is expected to increase by 2%, offsetting job losses in the chemical sector, while high energ...
Progress
52% Bias Score
PBMs Delay Life-Saving Medications: Urgent Call for Congressional Reform
A cancer center CEO details a 10-week delay in her daughter's medication approval due to PBM interference, highlighting the systemic issues causing patient suffering and the need for immediate Congressional reform to prioritize patients over profits, despite a failed attempt in 2024.
PBMs Delay Life-Saving Medications: Urgent Call for Congressional Reform
A cancer center CEO details a 10-week delay in her daughter's medication approval due to PBM interference, highlighting the systemic issues causing patient suffering and the need for immediate Congressional reform to prioritize patients over profits, despite a failed attempt in 2024.
Progress
60% Bias Score
Showing 97 to 108 of 152 results